This work aims to investigate the possible mechanism of action of the homologue peptide Pa-MAP based on the Antarctic fish Pleuronectes americanus, through a study by electrical impedance spectroscopy (EIS) of models of bilayer lipid membranes supported (BLM-s) on solid substrates. For comparison and validation of the data obtained by EIS, we also conducted a study evaluating the human peptide LL-37, whose mechanism of action is well described in the literature: its dielectric response was found to be similar to that of Pa-MAP. The results obtained indicate that Pa-MAP has a good potential for use as a membrane-disrupting peptide and also suggest that the corresponding mechanism of action occurs according to the carpet model followed by a detergent-like effect. The addition of either one of these peptides at different concentrations resulted in a drastic decrease in the membrane's resistance, after just 1min of exposure. Additionally, it was seen that the peptides Pa-MAP and LL-37 may act on membranes with different charges, in an indication of a possible broad spectrum antimicrobial activity. These interactions with different membrane compositions have been attributed to the peptides' structure, mainly due to the presence of many hydrophobic amino acid residues, as observed by in silico studies. Here, we describe the Pa-MAP mechanism of action for the first time. Furthermore, we report the data demonstrating that EIS can be used for studies of peptide-membranes interaction, even when small changes on the surface of the electrode can be detected.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.bbamem.2014.08.002 | DOI Listing |
Clin Cancer Res
January 2025
Stanford University, Palo Alto, CA, United States.
Purpose: After failing primary and secondary hormonal therapy, castration-resistant and neuroendocrine prostate cancer metastatic to the bone is invariably lethal, although treatment with docetaxel and carboplatin can modestly improve survival. Therefore, agents targeting biologically relevant pathways in PCa and potentially synergizing with docetaxel and carboplatin in inhibiting bone metastasis growth are urgently needed.
Experimental Design: Phosphorylated (activated) AXL expression in human prostate cancer bone metastases was assessed by immunohistochemical staining.
Sci Adv
January 2025
Life Science Center for Survival Dynamics, Tsukuba Advanced Research Alliance (TARA), University of Tsukuba, Tsukuba 305-8577, Japan.
PLoS One
January 2025
Heilongjiang University of Traditional Chinese Medicine, Harbin, Heilongjiang, China.
Hepatocellular carcinoma(HCC) has a high mortality and morbidity rate and seriously jeopardizes human life. Chemicals and chemotherapeutic agents have been experiencing problems such as side effects and drug resistance in the treatment of HCC, which cannot meet the needs of clinical treatment. Therefore, finding novel low-toxicity and high-efficiency anti-hepatocellular carcinoma drugs and exploring their mechanisms of action have become the current problems to be solved in the treatment of HCC.
View Article and Find Full Text PDFErgonomics
January 2025
Department of Industrial Engineering, Tsinghua University, Beijing, China.
This study investigated whether bidirectional transparency, compared to agent-to-human transparency, improved human-agent collaboration. Additionally, we examined the optimal transparency levels for both humans and agents. We assessed the impact of transparency direction and level on various metrics of a human-agent team, including performance, trust, satisfaction, perceived agent's teaming skills, and mental workload.
View Article and Find Full Text PDFInt Urol Nephrol
January 2025
Department of Urology, Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Tzu Chi University, Hualien, Taiwan.
Purpose: Urinary cytokine changes may serve as biomarkers to assess treatment outcomes for interstitial cystitis/bladder pain syndrome (IC/BPS). This study analyzed the changes in urinary cytokines following various bladder therapies and explored their clinical significance in therapeutic mechanisms.
Methods: A total of 122 patients with IC/BPS treated with platelet-rich plasma (PRP), botulinum toxin-A (BoTN-A), hyaluronic acid (HA), or low-energy shock wave (LESW) were evaluated.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!